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It has been estimated that an average adult human body is constituted by 
50 trillions (5 x 1013) cells. Although some cells like adult neurons, do not 
usually multiply, many others (e.g. blood cells) can and do divide in 
response to different challenges; most tissues are continually renewed 
thanks to the balance between programmed cell death and cell proliferation 
and differentiation. To generate and maintain such a complex and dynamic 
structure, a very tight and precise control system has to be active at any 
moment and in any individual cell. These regulations are assured by the 
"Genome", the full set of genes in an individual, either haploid or diploid. In 
a human, the haploid set contains more than 3 billion base pairs of DNA 
and about 50,000 genes.  
The human genome is contained in a set of 23 chromosomes which can be 
regarded as instructions books which we have inherited from our parents 
and that contain all the information needed to generate our body and 
maintain it in good health. Each cell of our body (also called somatic cell) 
receives two copies of the genome and uses this information to determine 
its exact role and destiny. The reproductive cells of our organism, called 
"Germ Cells", are an exception as they only receive one copy of the 
genome. The genes contained into these cells are those that will be passed 
to all the cells of the offspring. The different set of genes which we inherit 
from our parents specify not only our morphology, but also other more 
subtle characters such as our individual predisposition to diseases or our 
estimated life span. When mutation are present in germ cells they can be 
passed from one generation to another, they are at the origin of individual 
variations, but also of familial genetic diseases. When mutations occur in 
somatic cells, diseases of genetic origin, such as cancer can develop; in 
this case, however, the genetic lesion can not be transmitted from a 
generation to another.  
Since the origin of life on earth, more than 3.5 millions years ago, the 
spontaneous appearance of mutations in inherited genes has been at the 
basis of the mechanism of selection and evolution. Never was the 
phenotype capable to modify or improve the genotype of his offspring 
except by looking for a "better" potential marriage partner.  
We are witnessing, in the last decades, a remarkable progress in our 
knowledge of the nature and function of the genome which is paralleled by 
a tremendous technical progress in our capacities to manipulate the early 
human embryo. The combination of these new advances might soon open 
the possibility of curing genetic disorder and even designing the genetic 
profile of future individuals. This suggests that we might have the power, 
early in the twenty-first century, of determining what sort of people there 
should be.  
The aim of this paper is to evaluate which are the technical possibilities and 
limits to the manipulation of the human germ line which we can envisage 
for the next future. 
The main technological breakthroughs which occurred in "genomic" 
science in the last decades are: 
1. The genome of several organisms, including Drosophila has been 
completely sequenced and we are very close to know the complete 
sequence of the human genome. In other terms we have now opened the 
"books of life" written in our chromosomes and we know all the letters 
composing the text. This does not mean that we can yet understand what 
this text means. 
2. We have developed sophisticated techniques to analyse the function and 
regulation of genes in vivo. This means that we will be able soon to know 
the relation between the expression of a gene or of a set of genes and a 
phenotype and we will know how to activate or repress their expression. In 
other words we have the tools to understand the meaning of the text written 
in our chromosomes. 
3. The availability of very powerful computers and of new screening 
technologies gives us the possibility to know the genetic "profile" of 
individuals in large populations. This means that we will be able to 
associate characters such as predisposition to diseases with individual 
genomes. 
4. We have learned how to modify the genome of individuals and of their 
progeny. This can be done in two ways either by adding a new gene into a 
genome, creating a "transgenic" organism, or by creating specific 
"targeted" mutation in a genome. This last possibility opens the way to 
modify at will the genetic nature of an organism, for technical reasons (see 
below) this approach can only be applied for the moment to mice and man. 
5. We have developed very powerful technologies to manipulate and 
analyse the early human embryo. Some of these technologies are already 
used routinely; for example it is possible to remove one of the cells 
composing a very early embryo to study its genetic composition. This 
method, called "blastomer biopsy" is used to assure that couples at high 
risk of transmitting a genetic disease have a healthy child. 
6. In some case it has been possible to "clone" vertebrates. Genetically 
identical individuals could be obtained transferring a somatic nucleus to an 
egg. The efficiency of this technique is high only if the nucleus comes from 
an embryo, if the nucleus comes from a somatic cell of an adult animal to 
obtain one "normal" cloned individual hundreds of defective embryos were 
obtained. 
  
If in a couple is present a version of a gene that could predispose their 
offspring to inherit a condition they want to avoid, genetic manipulation may 
seem like a way to prevent the undesired outcome. One use proposed for 
germline modification has been to 'cleanse' the gene pool of 'deleterious' 
genes. For example, Daniel E. Koshland, Jr., a molecular biologist and the 
former editor-in-chief of Science, has written, "keeping diabetics alive with 
insulin, which increases the propagation of an inherited disease, seems 
justified only if one ultimately is willing to do genetic engineering to remove 
diabetes from the germ line and thus save the anguish and cost to millions 
of diabetics' (1). Some people also suggest that germline modification 
would enable couples to 'enhance' certain characteristics of their offspring 
(2). In the article referred to above, Koshland raises the possibility that 
germline alterations could meet future 'needs' to design individuals "better 
at computers, better as musicians, better physically." 
How can the human germline be modified ? Two possible paradigms are 
available to modify the genome in the germline. First of all it is possible to 
inject a segment of foreign DNA into an egg. In some cases (about 10% of 
the injected embryos) the injected fragment gets integrated into the 
genome. If the embryo then develops we will have obtained a "transgenic" 
animal. In mice and many other animals, the generation of transgenic 
individuals has actually proved technically quite easy. In the first widely-
reported successful experiment using the germline technique, an extra 
gene that promoted the synthesis of growth hormone was introduced into 
fertilized mouse eggs and the unusually high levels of the hormone made 
the mice grow to twice their normal size. Transgenic techniques are also 
being used to modify farm animals in attempts to increase yields of meat or 
enhance its nutritional quality, to cause them to produce pharmaceuticals in 
their milk, and to make their organs more suitable for human 
transplantation. 
Can we envisage to create, in the near future a transgenic human? 
Although, this techniques appears quite simple to apply, several technical 
problems are still unresolved. First of all, as mentioned above, only few of 
the injected embryos would actually become transgenic, one should 
therefore plan to inject many human eggs, let them develop in vitro and test 
them individually by blastomere biopsy to identify the few transgenics 
before re-implanting. A second problem consists in the fact that the foreign 
DNA integrates randomly into the genome, this can give rise to two 
different problems. First, the injected DNA could disrupt a normal gene and 
therefore cause the loss of its function (3) or, second, it might be integrated 
in a region of DNA which would induce its expression in undesired 
locations. This last problem (ectopic expression of the transgene) is quite 
common and almost unavoidable using classical transgenic technologies, 
when applied to humans it might cause undesirable and unpredictable 
effects. To avoid these last problems it has been suggested to inject into 
eggs "mini-chromosomes", long DNA fragments which would not integrate 
in the genome, but would add genetic material which would replicate and 
divide with the rest of the genome. If generating a classical transgenic 
organism corresponds to adding a page at random within the "book of life", 
this last solution would correspond to add one booklet of instructions to the 
set of 23 chromosomes. 
However, adding an extra gene would not, in many cases, help to cure a 
genetic disorder. Very often it would be essential to remove the defective 
gene and substitute it with a normal or enhanced version. This type of 
genetic manipulation is routinely done on mice thanks to a technology 
known as "homologous recombination". The technique is based on the fact 
that complementary stretches of DNA tend to pair. If one injects into a cell a 
DNA fragment containing appropriate regions homologous to the genomic 
DNA then the fragment will integrate in a specific location of the genome 
and substitute an existing gene. With this technique is therefore possible to 
correct specific mutations without altering the rest of the DNA. Some 
technical problems are, however, present. First of all the appropriate 
insertion of the DNA fragment is a very rare event. It is therefore necessary 
to inject the fragment in many thousand cells in order to select a single cell 
with the expected mutation. The technique consists therefore in inserting 
the mutation in "Embryonic Stem Cells" (ES cells), cells derived from very 
early embryos which can be grown at will and that, when re-injected into 
another early embryo have the capacity to give rise to any tissue, including 
germ cells. ES cells can at the moment be obtained only from mouse and 
human embryos. The technique of homologous recombination has been 
widely used to reproduce in the mouse the genetic lesions which give rise 
to human genetic diseases. It has also been used to inactivate mouse 
genes (the so-called knock-out mice) to study their function in vivo.  
Will homologous recombination be ever applied to correct human genetic 
disorders or to introduce new genes into the human species ? Technically it 
does not seem impossible. We already have all the instruments to conceive 
such an experiment. We should generate ES cells from an embryo, modify 
them in vitro by homologous recombination and then use a nucleus from 
the "cured" cell to clone a new individual using an egg derived from the 
same mother from which the ES cells were derived. This technical 
approach will permit for the first time to correct the stigma of a genetic 
disorder without having to suppress mutant individuals. This approach 
seems actually much more precise and safe than the creation of transgenic 
humans as we will have a complete control on the DNA modification which 
we are introducing.  
In conclusion, although many technical problems remain still to be solved, it 
appears that germline manipulation in humans is certainly conceivable and 
that it will most probably be implemented in the near future. The ethical, 
social, economic implication of these new technical possibilities are being 
investigated by many thinkers and decision makers (see for example ref. 
2). However, the most important implication remains that for the first time 
since the creation of life a new mechanism of evolution is getting into place. 
The speed of adaptation of our species to sudden environmental 
challenges could be greatly increased in the future giving us the hope to 
adapt and survive to sudden climatic and environmental changes.  
A new destiny for the human species ? A new future for life ? 
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